⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL284306 | 1.00 | — | — | |
| SCHEMBL384942 | 1.00 | — | — | |
| SCHEMBL763906 | 0.78 | — | — | |
| SCHEMBL20334036 | 0.78 | — | — | |
| SCHEMBL10225212 | 0.78 | — | — | |
| SCHEMBL12647089 | 0.78 | — | — | |
| SCHEMBL2568753 | 0.75 | — | — | |
| SCHEMBL386340 | 0.75 | — | — | |
| SCHEMBL7919434 | 0.75 | — | — | |
| SCHEMBL23170009 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023195865-A1 | MEDICAL GASES CONDUIT | FISHER & PAYKEL HEALTHCARE LIMITED (NZ) | 2023-10-12 | — | — | WO | disclosed |
| US-20230295368-A1 | CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-4234553-A2 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| US-11718704-B2 | Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20230059470-A1 | BASE PLATE AND SENSOR ASSEMBLY OF AN OSTOMY SYSTEM HAVING A LEAKAGE SENSOR | COLOPLAST A/S (DK) | 2023-02-23 | — | — | US | disclosed |
| WO-2021186180-A1 | IMIDAZOLYL THIOPEHENE SULFONYL CARBAMATES FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOTENSIN II | VICORE PHARMA AB (SE) | 2021-09-23 | — | — | WO | disclosed |
| EP-3630752-B1 | SUBSTITUTED NITROGEN CONTAINING COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2021-06-30 | — | — | EP | disclosed |
| EP-2635307-B1 | PHARMACEUTICAL COMPOSITIONS | MELINTA SUBSIDIARY CORP (US) | 2020-07-29 | — | — | EP | disclosed |
| US-10253408-B2 | Compound, thin film-forming material, and thin film manufacturing method | ADEKA CORPORATION (JP) | 2019-04-09 | — | — | US | disclosed |
| EP-3312187-A1 | METHOD FOR MANUFACTURING NOVEL COMPOUND, RAW MATERIAL FOR THIN FILM FORMATION, AND THIN FILM | Adeka Corporation (JP) | 2018-04-25 | — | — | EP | disclosed |
| WO-2007041365-A2 | 3-CYCLYL-2- (4-SULFAMO YL-PHENYL) -N-CYCLYL-PROPIONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF IMPAIRED GLUCOSE TOLERANCE AND DIABETES | NOVARTIS AG (CH) | 2007-04-12 | — | — | WO | disclosed |
| US-20070078120-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| EP-1377556-B1 | PYRAZOLE DERIVATIVES FOR TREATING HIV | PFIZER LTD (GB) | 2007-04-04 | — | — | EP | disclosed |
| EP-1762567-A1 | Pyrazole derivatives for treating HIV | Pfizer Limited (GB) | 2007-03-14 | — | — | EP | disclosed |
| US-7186719-B2 | Antibacterial agents | BRITISH BIOTECH PHARMACEUTICALS (GB) | 2007-03-06 | — | — | US | disclosed |
| EP-1745784-A1 | Oxazolidinone derivatives and use thereof as antibiotics | FERRER INTERNACIONAL, S.A. (ES) | 2007-01-24 | — | — | EP | disclosed |
| WO-2007000432-A1 | OXAZOLIDINONE DERIVATIVES AND USE THEREOF AS ANTIBIOTICS | FERRER INTERNACIONAL, S. A. (ES) | 2007-01-04 | — | — | WO | disclosed |
| US-20070004675-A1 | Inhibitors of VEGF receptor and HGF receptor signaling | METHYLGENE, INC. | 2007-01-04 | — | — | US | disclosed |
| EP-1739081-A1 | HYDRAZINO-SUBSTITUTED HETEROCYCLIC NITRILE COMPOUNDS AND USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-7157424-B2 | Pharmaceutical compositions for hepatitis C viral protease inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-02 | — | — | US | disclosed |